Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 165.72 8.3 (5.27%) Market Cap: 20.96 Bil Enterprise Value: 19.89 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 67/100

Alnylam Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 02:50PM GMT
Release Date Price: $162 (-0.61%)
Ritu Subhalaksmi Baral
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Good morning, everyone. Welcome to day 2 of the 2022 Cowen Healthcare Conference. Thanks for joining us for the Alnylam fireside chat today. I'm covering biotech analyst, Ritu Baral. And with us from Alnylam today, Akshay Vaishnaw, President and Head of R&D for Alnylam.

Akshay, thanks so much for joining us today. Relatively recent promotion for you, end of last year, correct? So congratulations. I do have to say I still love the fuzzy dice in the back. I'm glad you didn't take those down.

Akshay K. Vaishnaw
Alnylam Pharmaceuticals, Inc. - President

I keep those on there for you, Ritu. I'm delighted to be here with you. Thank you.

Questions & Answers

Ritu Subhalaksmi Baral
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Which brings us to my first question of what you think the placebo effect in APOLLO-B is going to be. I'm kidding. You wouldn't rely on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot